News

Albuquerque, NM Kirsten Dimmler, a Bioinformatics Analyst at EquiSeq, has accepted an offer of admission to graduate school in the College of Veterinary Medicine at the University of Minnesota. Kirsten will be entering the laboratory of Dr. Molly McCue, a leading veterinary expert in the field of equine genetics and genomics. Her admission to graduate…

Saint Paul, Minnesota The Equine Genetics and Genomics Laboratory at the University of Minnesota is conducting a study using 3,000+ horses to study the genetic mechanisms behind different muscle disorders in horses and how diet and exercise may impact these disorders. The results of this study will provide veterinarians, researchers, and horse owners with information…

Fayetteville, AR At the Al Khamsa Annual Meeting and Convention  today in Fayetteville, Arkansas, EquiSeq announced that it has added the P8 and K1 tests to the Myopathy Panel at no extra cost. EquiSeq’s Myopathy Panel, priced at $249, now includes tests for P2, P3, P4, Px, P8, and K1. The P8 and K1 genetic variants are…

FASTER HORSES  EquiSeq decodes equine genetics for better health and performanceBy Leslie Linthicum At the core of most living things is the genome, the package of genetic materials stored in long molecules of DNA. It’s what makes a person, a whale or a blob of algae grow and develop different characteristics. And it is at…

Tuebingen CAG GmbH – Center for Animal Genetics has signed an agreement with EquiSeq to be the exclusive testing center for their Equine Myopathy Panel in Europe. Horse owners can now test their animals without requiring an invasive blood draw or muscle biopsy. Equine Myopathy Panel tests for mutations in three genes associated with Polysaccharide…

By Collin Krabbe – Technology reporter , Albuquerque Business FirstJul 23, 2018, 2:33pm MDT  Albuquerque-based biotechnology company EquiSeq has been busy with two new developments: the hire of a new chief executive and a fresh licensing agreement. Alex Hafez is the firm’s new CEO. He is pursuing a dual-degree from the University of New Mexico…

Albuquerque, NM EquiSeq today disclosed the genes affected by the P2, P3, and P4 genetic variants that are part of its Myopathy Panel. The genetic variants are in part responsible for Polysaccharide Storage Myopathy type 2 (PSSM2), also known as Myofibrillar Myopathy (MFM). The genes affected by the P2, P3, and P4 genetic variants were…

EquiSeq is conducting a study of the effect of myopathy variants (P2, P3, and P4) on Thoroughbred performance. We seek registered Thoroughbreds of any age for this study. To have your Thoroughbred included in the study, you must be a horse owner in the United States with one or more registered Thoroughbreds. Your Thoroughbred must…

ALBUQUERQUE, N.M. Albuquerque startup EquiSeq dominated the slopes this year at the third annual ski lift pitch competition, beating out 11 other companies to win a $10,000 prize at the Taos Ski Valley on Tuesday. The competition, organized by Albuquerque’s ABQid business accelerator, is a novel twist on pitch competitions that places competing companies on…

Episode 2 of Startup Spot with Sonja, I interview Paul Szauter, Chief Scientific Officer, and Lexie Palmer, CEO of Equiseq. Hear about how their business is changing after researching their original direction. Continue Reading »